Instituto de Tecnologia em Imunobiológicos, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.
Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.
Cad Saude Publica. 2020 Sep 21;36Suppl 2(Suppl 2):e00182019. doi: 10.1590/0102-311X00182019. eCollection 2020.
Immunization is one of the most effective measures to protect individuals and the population against vaccine-preventable diseases. Vaccines are safe and effective products, but like any other drug they can cause adverse events, which tend to become more visible as the diseases are controlled, eliminated, or eradicated. This study analyzed activities in the surveillance of adverse events following immunization (AEFI) based on data from the scientific literature, websites of immunization programs and health andregulatory agencies, and the authors' expertise in the areas of immunizations and pharmacovigilance. With the increase in the number of vaccines in the basic immunization schedule and expansion of the population's access, it has become essential to establish an efficient surveillance system for AEFI in Brazil. However, underreporting of cases in Brazil and in other countries hinders the detection of AEFI, especially rare events. Constantly updated information on vaccines' risks and benefits allows immunization programs to provide rapid and clear responses to rumors of AEFI. This ensures the system's reliability, especially in the face of the growing antivaccine movement and the increasing influence of social media in public opinion.
免疫接种是保护个人和人群免受疫苗可预防疾病的最有效措施之一。疫苗是安全有效的产品,但与任何其他药物一样,它们也可能引起不良反应,而且随着疾病的控制、消除或消灭,不良反应往往变得更加明显。本研究基于文献资料、免疫规划和卫生与监管机构网站上的数据以及作者在免疫接种和药物警戒领域的专业知识,分析了疫苗接种后不良反应(AEFI)监测活动。随着基础免疫规划中疫苗数量的增加和人群可获得性的扩大,巴西建立有效的 AEFI 监测系统变得至关重要。然而,巴西和其他国家的病例漏报情况阻碍了 AEFI 的检测,尤其是罕见事件。不断更新的疫苗风险和效益信息使免疫规划能够对 AEFI 的谣言迅速作出明确回应。这确保了该系统的可靠性,特别是在面对日益增长的反疫苗运动和社交媒体对公众舆论的日益影响时。